CA/MAO-B-IN-1 (Compound 78) is a dual inhibitor for human brain carbonic anhydrases (CA) and Monoamine Oxidase-B (MAO-B), with IC50s of 8.8 and 7.0 nM, respectively. CA/MAO-B-IN-1 reveals a human oral absorption of 71.9% through in silico prediction.
CA/MAO-B-IN-1 (12.5-50 μM) reverts formation of ROS, exhibits neuro- and mitochondrial protective effects against Aβ1-42 oligomer-induced neurotoxicity in cells SH-SY5Y[1].